These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

318 related items for PubMed ID: 11110623

  • 1. Update on peripheral arterial vasodilation, ascites and hepatorenal syndrome in cirrhosis.
    Knotek M, Rogachev B, Schrier RW.
    Can J Gastroenterol; 2000 Nov; 14 Suppl D():112D-121D. PubMed ID: 11110623
    [Abstract] [Full Text] [Related]

  • 2. Fluid retention in cirrhosis: pathophysiology and management.
    Kashani A, Landaverde C, Medici V, Rossaro L.
    QJM; 2008 Feb; 101(2):71-85. PubMed ID: 18184668
    [Abstract] [Full Text] [Related]

  • 3. Pathogenetic factors and clinical elements in ascites and hepatorenal syndrome during liver cirrhosis.
    Gentilini P, Laffi G, La Villa G, Raggi VC.
    Ann Ital Med Int; 1999 Feb; 14(4):264-84. PubMed ID: 10638019
    [Abstract] [Full Text] [Related]

  • 4. Peripheral arterial vasodilation hypothesis: a proposal for the initiation of renal sodium and water retention in cirrhosis.
    Schrier RW, Arroyo V, Bernardi M, Epstein M, Henriksen JH, Rodés J.
    Hepatology; 1988 Feb; 8(5):1151-7. PubMed ID: 2971015
    [Abstract] [Full Text] [Related]

  • 5. Management of ascites and hepatorenal syndrome.
    Piano S, Tonon M, Angeli P.
    Hepatol Int; 2018 Feb; 12(Suppl 1):122-134. PubMed ID: 28836115
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Complications of cirrhosis. II. Renal and circulatory dysfunction. Lights and shadows in an important clinical problem.
    Arroyo V, Jiménez W.
    J Hepatol; 2000 Feb; 32(1 Suppl):157-70. PubMed ID: 10728802
    [Abstract] [Full Text] [Related]

  • 8. Ascites and hepatorenal syndrome: pathophysiology and management.
    Roberts LR, Kamath PS.
    Mayo Clin Proc; 1996 Sep; 71(9):874-81. PubMed ID: 8790265
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Ascites in liver diseases.
    Gentilini P, Laffi G.
    Ann Ital Med Int; 1991 Sep; 6(1 Pt 2):148-55. PubMed ID: 1742150
    [Abstract] [Full Text] [Related]

  • 11. Diagnosis and therapy of ascites in liver cirrhosis.
    Biecker E.
    World J Gastroenterol; 2011 Mar 14; 17(10):1237-48. PubMed ID: 21455322
    [Abstract] [Full Text] [Related]

  • 12. Hyponatremia in Cirrhosis: An Update.
    Alukal JJ, John S, Thuluvath PJ.
    Am J Gastroenterol; 2020 Nov 14; 115(11):1775-1785. PubMed ID: 33156095
    [Abstract] [Full Text] [Related]

  • 13. Type-2 hepatorenal syndrome and refractory ascites: role of transjugular intrahepatic portosystemic stent-shunt in eighteen patients with advanced cirrhosis awaiting orthotopic liver transplantation.
    Testino G, Ferro C, Sumberaz A, Messa P, Morelli N, Guadagni B, Ardizzone G, Valente U.
    Hepatogastroenterology; 2003 Nov 14; 50(54):1753-5. PubMed ID: 14696397
    [Abstract] [Full Text] [Related]

  • 14. Practical recommendations for the treatment of ascites and its complications.
    Bataller R, Ginès P, Arroyo V.
    Drugs; 1997 Oct 14; 54(4):571-80. PubMed ID: 9339961
    [Abstract] [Full Text] [Related]

  • 15. Refractory ascites: pathogenesis, definition and therapy of a severe complication in patients with cirrhosis.
    Salerno F, Guevara M, Bernardi M, Moreau R, Wong F, Angeli P, Garcia-Tsao G, Lee SS.
    Liver Int; 2010 Aug 14; 30(7):937-47. PubMed ID: 20492521
    [Abstract] [Full Text] [Related]

  • 16. Ascites and Hepatorenal Syndrome.
    Adebayo D, Neong SF, Wong F.
    Clin Liver Dis; 2019 Nov 14; 23(4):659-682. PubMed ID: 31563217
    [Abstract] [Full Text] [Related]

  • 17. Management of ascites in cirrhosis.
    Sandhu BS, Sanyal AJ.
    Clin Liver Dis; 2005 Nov 14; 9(4):715-32, viii. PubMed ID: 16207572
    [Abstract] [Full Text] [Related]

  • 18. Review article: pathogenesis and pathophysiology of hepatorenal syndrome--is there scope for prevention?
    Møller S, Henriksen JH.
    Aliment Pharmacol Ther; 2004 Sep 14; 20 Suppl 3():31-41; discussion 42-3. PubMed ID: 15335398
    [Abstract] [Full Text] [Related]

  • 19. Management of ascites in patients with end-stage liver disease.
    Saadeh S, Davis GL.
    Rev Gastroenterol Disord; 2004 Sep 14; 4(4):175-85. PubMed ID: 15580152
    [Abstract] [Full Text] [Related]

  • 20. Review: the controversy over the pathophysiology of ascites formation in cirrhosis.
    Wong F, Girgrah N, Blendis L.
    J Gastroenterol Hepatol; 1997 Jun 14; 12(6):437-44. PubMed ID: 9195401
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.